Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers E > Headlines for Endo Pharmaceuticals Holdings Inc. > News item |
D.E. Shaw reports sale of 1.9 million shares of Endo Pharmaceuticals
By Lisa Kerner
Charlotte, N.C., Aug. 28 - D.E. Shaw Valence Portfolios, LLC reduced its interest in Endo Pharmaceuticals Holdings Inc. to 8.2% with the sale of 1,904,988 shares between June 25 and Aug. 27.
The shares were priced from $17.11 to $22.52 each, it was reported in a schedule 13D/A filed on Friday with the Securities and Exchange Commission.
D.E. Shaw beneficially owns 9,646,882 shares of the Chadds Ford, Pa., pharmaceutical company's common stock.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.